Literature DB >> 8513577

Elevated levels of antibodies against sulphatide are present in all chronic chagasic and dilated cardiomyopathy sera.

J L Avila1, M Rojas, H Carrasco.   

Abstract

A natural anti-sulphatide antibody was found to be present in the serum of every normal individual studied. The reactivity of the antibody was assessed by its interaction with galactosylceramide-I3-sulphate. Antigen-antibody binding was strongly blocked by 1 mM heparin, dextran sulphate and chondroitin sulphate A, and by 5 mM chondroitin sulphate B. Antibodies avidly absorb to rabbit erythrocytes, but discretely to rat erythrocytes, suggesting that they are different from galactocerebroside antibodies. Elevated levels of sulphatide antibodies were present in all of 102 chronic Trypanosoma cruzi-infected patients studied, but not in other patients having cutaneous or visceral leishmaniasis, T. rangeli infection or several other protozoal, helminthic or mycotic infections. Interestingly, 100% of 40 dilated cardiomyopathy patients also have elevated levels of sulphatide antibodies. As T. cruzi is rich in galactocerebroside sulphate, it is proposed that in chagasic patients this glycolipid could act as an immunogen, inducing elevated titres of sulphatide antibodies, which could be important in the pathogenesis of cardiac or peripheral nerve symptoms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513577      PMCID: PMC1554782          DOI: 10.1111/j.1365-2249.1993.tb03421.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Autoimmune phenomena in chronic chagasic cardiopathy.

Authors:  L Hudson
Journal:  Parasitol Today       Date:  1985-07

2.  Elevated cerebroside antibody levels in human visceral and cutaneous leishmaniasis, Trypanosoma rangeli infection, and chronic Chagas' disease.

Authors:  J L Avila; M Rojas
Journal:  Am J Trop Med Hyg       Date:  1990-07       Impact factor: 2.345

3.  Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies.

Authors:  H J Willison; B D Trapp; J D Bacher; M C Dalakas; J W Griffin; R H Quarles
Journal:  Muscle Nerve       Date:  1988-11       Impact factor: 3.217

4.  Trypanosoma cruzi: defined medium for continuous cultivation of virulent parasites.

Authors:  J L Avila; A Bretaña; M A Casanova; A Avila; F Rodríguez
Journal:  Exp Parasitol       Date:  1979-08       Impact factor: 2.011

5.  [A 4 year follow-up study in a rural community with an epidemic of chagasic disease].

Authors:  J J Puigbó; J R Nava Rhode; H García Barrios; C Gil Yépez
Journal:  Bol Oficina Sanit Panam       Date:  1969-02

6.  Antibodies against sulphatide in sera from patients with autoimmune rheumatic diseases.

Authors:  S Aotsuka; M Okawa-Takatsuji; S Uwatoko; R Yokohari; Y Ikeda; G Toda
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

7.  Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora.

Authors:  U Galili; R E Mandrell; R M Hamadeh; S B Shohet; J M Griffiss
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

8.  Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in northeast Brazil.

Authors:  J H Maguire; K E Mott; J S Lehman; R Hoff; T M Muniz; A C Guimarães; I Sherlock; R H Morrow
Journal:  Am Heart J       Date:  1983-02       Impact factor: 4.749

9.  In vivo incorporation of palmitic acid and galactose in glycolipids of Trypanosoma cruzi epimastigotes.

Authors:  R M de Lederkremer; B Zingales; A N Confalonieri; A S Couto; N F Martin; W Colli
Journal:  Biochem Int       Date:  1985-01

Review 10.  Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system.

Authors:  R H Quarles; A A Ilyas; H J Willison
Journal:  Chem Phys Lipids       Date:  1986-12-15       Impact factor: 3.329

View more
  3 in total

1.  Presentation of the same glycolipid by different CD1 molecules.

Authors:  A Shamshiev; H-J Gober; A Donda; Z Mazorra; L Mori; G De Libero
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

2.  Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation.

Authors:  Laura Pérez-Campos Mayoral; María Teresa Hernández-Huerta; Dulce Papy-García; Denis Barritault; Edgar Zenteno; Luis Manuel Sánchez Navarro; Eduardo Pérez-Campos Mayoral; Carlos Alberto Matias Cervantes; Margarito Martínez Cruz; Gabriel Mayoral Andrade; Malaquías López Cervantes; Gabriela Vázquez Martínez; Claudia López Sánchez; Socorro Pina Canseco; Ruth Martínez Cruz; Eduardo Pérez-Campos
Journal:  Mol Cell Biochem       Date:  2021-06-10       Impact factor: 3.396

3.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.